Kura Oncology's total assets for Q4 2025 were $738.36M, an increase of 13.70% from the previous quarter. DE:KUR total liabilities were $564.23M for the fiscal quarter, a 38.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.